On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Institut de Recherches Medicales et D'Etudes des Plantes Medicinales's own share of each project, not the project's full budget.
- Horizon Europe€1.0M · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- ELDORADOPartner
Toxicity of dolutegravir and evaluation of doravirine for alternative 1st line antiretroviral treatment in people living with HIV
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€1.0Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- The University of SheffieldUnited Kingdom · 1 shared project
- Assistance Publique Hopitaux de ParisFrance · 1 shared project
- Universite de BordeauxFrance · 1 shared project
- Institut de Recherche Pour le DeveloppementFrance · 1 shared project
- Instituto Nacional de SaúdeMozambique · 1 shared project
- Fundacao Oswaldo CruzBrazil · 1 shared project
- Association Pac-CiCôte d’Ivoire · 1 shared project
- Adera SASFrance · 1 shared project
- Faculty of Associated Medical Sciences, Chiang Mai UniversityThailand · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- HIV
- diabetes
- obesity
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.